InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,933.55
(
1.66%
)
Post# of 402722
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BooDog

Send PM Follow Ignore
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

BooDog

Re: None

Thursday, 04/19/2018 10:04:45 AM

Thursday, April 19, 2018 10:04:45 AM

Post# of 402722
$IPIX CORPORATE OVERVIEW AND CATALYSTS

Corporate overview April 2018

https://static1.squarespace.com/static/5715352e20c647639137f992/t/5acbbec2562fa79982ad5e22/1523302089564/2018+Apr+IPIX+Corporate+Overview.pdf

Clinical trials...ALL SUCCESSFUL TO DATE

https://clinicaltrials.gov/ct2/results?term=cellceutix&Search=Search

Catalysts

Brilacidin _OM breakthrough designation

Prurisol data phase 2b double blinded, last patient visit announced December 21st.

Kevetrin oral formulation toxicology

Brilacidin partnership/licensing

UP LISTING

Press releases...
https://www.ipharminc.com/press-release/

Patents

- Kevetrin
https://www.google.com/patents/US8338454

- Brilacidin
https://www.sec.gov/Archives/edgar/data/1355250/000147793214002418/ctix_ex1037.htm
https://www.google.com/patents/US20160243117
https://www.google.com/patents/EP2709619A2

- Prurisol
https://www.google.com/patents/WO2013103601A1

MP Advisors Report

https://drive.google.com/file/d/0Bz15O4eaX-asWVpoclB2WUhENFk/view



$IPIX

see you guys on the big boards!

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!